117 related articles for article (PubMed ID: 16772869)
1. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease.
Lagalwar S; Guillozet-Bongaarts AL; Berry RW; Binder LI
J Neuropathol Exp Neurol; 2006 May; 65(5):455-64. PubMed ID: 16772869
[TBL] [Abstract][Full Text] [Related]
2. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
3. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
4. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
5. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
6. [Argyrophilic grain disease (AgD), a frequent and largely underestimated cause of dementia in old patients].
Probst A; Tolnay M
Rev Neurol (Paris); 2002 Feb; 158(2):155-65. PubMed ID: 11965171
[TBL] [Abstract][Full Text] [Related]
7. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
8. c-Jun phosphorylation in Alzheimer disease.
Thakur A; Wang X; Siedlak SL; Perry G; Smith MA; Zhu X
J Neurosci Res; 2007 Jun; 85(8):1668-73. PubMed ID: 17455299
[TBL] [Abstract][Full Text] [Related]
9. Atypical protein kinase C in neurodegenerative disease I: PKMzeta aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease.
Crary JF; Shao CY; Mirra SS; Hernandez AI; Sacktor TC
J Neuropathol Exp Neurol; 2006 Apr; 65(4):319-26. PubMed ID: 16691113
[TBL] [Abstract][Full Text] [Related]
10. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
12. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.
Schönheit B; Zarski R; Ohm TG
Neurobiol Aging; 2004 Jul; 25(6):697-711. PubMed ID: 15165691
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.
Maeda S; Sahara N; Saito Y; Murayama S; Ikai A; Takashima A
Neurosci Res; 2006 Mar; 54(3):197-201. PubMed ID: 16406150
[TBL] [Abstract][Full Text] [Related]
14. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
15. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
Su JH; Deng G; Cotman CW
Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
[TBL] [Abstract][Full Text] [Related]
16. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
17. Abnormal processing of tau in the brain of aged TgCRND8 mice.
Bellucci A; Rosi MC; Grossi C; Fiorentini A; Luccarini I; Casamenti F
Neurobiol Dis; 2007 Sep; 27(3):328-38. PubMed ID: 17656099
[TBL] [Abstract][Full Text] [Related]
18. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
Rapp MA; Schnaider-Beeri M; Grossman HT; Sano M; Perl DP; Purohit DP; Gorman JM; Haroutunian V
Arch Gen Psychiatry; 2006 Feb; 63(2):161-7. PubMed ID: 16461859
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
20. Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
Haroutunian V; Davies P; Vianna C; Buxbaum JD; Purohit DP
Neurobiol Aging; 2007 Jan; 28(1):1-7. PubMed ID: 16343696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
